Skip to main content
Figure 7 | Molecular Neurodegeneration

Figure 7

From: Neuromuscular effects of G93A-SOD1 expression in zebrafish

Figure 7

Neuromuscular phenotype of transgenic ALS zebrafish. Transgenic G93A-SOD1-GFP zebrafish exhibit denervation at the NMJ around 20 weeks of age, subsequent alterations in innervation patterns at 30 weeks of age, and evidence of MN loss around 40 weeks of age which reflect a sequence of events that resembles the human disease course.

Back to article page